Who is sponsoring NCT05712525?

NCT05712525 is sponsored by G-Tech Corporation.

What drugs are being tested in NCT05712525?

Interventions in NCT05712525: G-Tech Wireless Patch System (WPS).

What condition does NCT05712525 study?

NCT05712525 studies Gastrointestinal Diseases, Ileus.

Is NCT05712525 still recruiting?

NCT05712525 is currently status unknown. Last updated 3 February 2023.

Last reviewed 2023-02-03 · How we verify

NCT05712525: GRIPS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Gut Recovery In Patients Following Surgery

Status unknown Last updated 3 February 2023

What this trial tests

trial testing G-Tech Wireless Patch System (WPS) in Gastrointestinal Diseases in 150 participants. Status unknown.

Timeline

7 October 2022

Primary endpoint
6 October 2023

6 October 2024

Quick facts

Lead sponsor	G-Tech Corporation
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	150
Start date	7 October 2022
Primary completion	6 October 2023
Estimated completion	6 October 2024
Sites	1 location across United States

Drugs / interventions tested

G-Tech Wireless Patch System (WPS)

Conditions studied

Gastrointestinal Diseases — all drugs for Gastrointestinal Diseases →
Ileus — all drugs for Ileus →

Sponsor

G-Tech Corporation

Who can join

18 and older, any sex, with Gastrointestinal Diseases or Ileus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to determine if the myoelectrical measurements made by the G-Tech Wireless Patch System correlate with clinical markers of postoperative recovery such as passage of flatus/bowel movement, oral tolerance of diet and discharge readiness. Subsequently the data will be studied to establish which information in the signals is important in determining when to feed patients and possibly discharge them..

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Gastrointestinal Diseases

Currently open trials in the same condition.

NCT07351071 — Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Res · NA · recruiting
NCT07222800 — Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult · Phase 3 · recruiting
NCT06271538 — Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome · Phase 4 · recruiting
NCT06579170 — Burden of Recreational Water Illness Due to Exposure to Cyanobacteria and Their Toxins in Freshwater Beaches in Canada · active not recruiting
NCT06290258 — Fecal Microbiota Transplantation for Patients With Autism Spectrum Disorder. · Phase 1, PHASE2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05712525 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by G-Tech Corporation
Last refreshed: 3 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05712525.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing